Dhampur Bio Q3 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- The company expects an increase in cane crushing compared to last year, leading to higher overall production volumes.
- Despite crushing more cane, overall sugar production is expected to decline due to higher diversion of cane towards ethanol production and lower sugar recovery rates.
- Ethanol production is anticipated to maximize, supported by enhanced distillery capacity commissioned last year and stable distillery operations post shutdown.
- The mix between biofuels (ethanol) and sugar is shifting towards greater ethanol production.
- Revenue from biofuel segment has shown significant growth and is expected to continue improving with increased ethanol sales and country liquor production.
- Export of sugar is planned to fully utilize the allocated export quota, enhancing sales volumes abroad.
- The company is focusing on capacity optimization, value addition (e.g., pharma-grade sugar), and expansion opportunities like ethanol capacity debottlenecking to sustain growth.
See what Dhampur Bio management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No explicit mention of any current or future fundraising through debt or equity in the provided transcript.
- The company has repaid Rs. 14.94 crores of long-term loans during the quarter, with long-term loans standing at Rs. 249.53 crores as of 31st December 2022.
- Working capital as on 31st December 2022 stood at Rs. 307 crores compared to Rs. 285 crores a year ago.
- Fresh term loans of Rs. 129 crores were availed for CAPEX undertaken during the year.
- Management is actively debating potential expansion, especially regarding ethanol capacity, but no concrete fundraising plans have been announced.
- Any future plans for capacity expansion or related projects will be discussed internally and with the Board before announcing.
See what Dhampur Bio management said on order book — free account, 30 seconds.
Capex plans
Yes- The company is actively debating increasing ethanol capacity through debottlenecking and considering expansion.
- There are ongoing internal discussions along with the Board to decide on the most opportune time for ethanol capacity increase.
- The management is also exploring potential investments in other related products downstream.
- The expansion plans are connected to sugarcane area and yield improvements; optimism exists due to increased cane area and efforts to control pests.
- No definitive CAPEX decisions or timelines have been shared yet; plans will be articulated once finalized.
Track Dhampur Bio — get its next earnings analysis in your feed
How does Dhampur Bio rank vs peers in Agricultural Food & other Products?
Pro featureHow does Dhampur Bio rank in Agricultural Food & other Products?
Compare Dhampur Bio against every Agricultural Food & other Products company (Q3 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Dhampur Bio's management said in earlier quarters
Others in Agricultural Food & other Products this season
- M.V.K. Agro (Q2 FY27)
For the quarter ended September 30, 2026, MVK Agro Food Product Ltd reported revenue from operations of ₹6,145.91 lakhs, up from ₹4,215.70 lakhs in the same…
- Gokul Refoils (Q2 FY27)
17,449.65 lakhs (approximately 16.4% growth) . Key results statement takeaways from Gokul Refoils and Solvent Ltd's Q2 FY27 results statement — and how it ranks
- Patanjali Foods (Q2 FY27)
11,322.58 crores, up 15.55% YoY. Key results statement takeaways from Patanjali Foods Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- GRM Overseas (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹452.6 Cr, up 22% YoY from ₹372.4 Cr in Q2 FY26 (Page 8) . Key investor presentation takeaways from GRM Overseas Ltd's Q2 FY27